CCL4 and Alzheimer disease: Bayesian colocalization analysis demonstrated strong genetic evidence (PP4 > 0.85) for shared causal mechanisms between MMP1 and CCL4 with AD protection in the prefrontal cortex, establishing them as priority therapeutic targets and further verifying the results of MR analysis.